Published in Proc Natl Acad Sci U S A on December 10, 2008
Prions. Cold Spring Harb Perspect Biol (2011) 3.17
Molecular mechanisms for protein-encoded inheritance. Nat Struct Mol Biol (2009) 1.94
Aerosols transmit prions to immunocompetent and immunodeficient mice. PLoS Pathog (2011) 1.71
Cell biology: Beyond the prion principle. Nature (2009) 1.70
Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape. Chem Rev (2010) 1.62
Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J Chem Biol (2009) 1.55
Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease. PLoS Pathog (2015) 1.54
Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron (2009) 1.49
The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog (2011) 1.49
Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol (2009) 1.42
A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest (2010) 1.41
Prion hypothesis: the end of the controversy? Trends Biochem Sci (2010) 1.40
Coinfecting prion strains compete for a limiting cellular resource. J Virol (2010) 1.32
Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem (2011) 1.29
A new mechanism for transmissible prion diseases. J Neurosci (2012) 1.25
Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor. PLoS Pathog (2009) 1.21
Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog (2011) 1.17
The immunobiology of prion diseases. Nat Rev Immunol (2013) 1.13
Chronic wasting disease (CWD) susceptibility of several North American rodents that are sympatric with cervid CWD epidemics. J Virol (2010) 1.11
Review: contribution of transgenic models to understanding human prion disease. Neuropathol Appl Neurobiol (2010) 1.11
High-resolution structure of infectious prion protein: the final frontier. Nat Struct Mol Biol (2012) 1.09
Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates. Org Biomol Chem (2011) 1.08
Biochemical properties of highly neuroinvasive prion strains. PLoS Pathog (2012) 1.07
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J (2009) 1.07
Rapid transepithelial transport of prions following inhalation. J Virol (2012) 1.04
Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci U S A (2012) 1.03
Evidence that bank vole PrP is a universal acceptor for prions. PLoS Pathog (2014) 1.03
Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins. J Virol (2012) 1.01
Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein. J Neurosci (2011) 0.99
Mouse models for studying the formation and propagation of prions. J Biol Chem (2014) 0.98
Dynamic diagnosis of familial prion diseases supports the β2-α2 loop as a universal interference target. PLoS One (2011) 0.98
In vitro generation of high-titer prions. J Virol (2011) 0.97
Prion proteins with pathogenic and protective mutations show similar structure and dynamics. Biochemistry (2009) 0.97
Profoundly different prion diseases in knock-in mice carrying single PrP codon substitutions associated with human diseases. Proc Natl Acad Sci U S A (2013) 0.94
Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry (2011) 0.93
Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates. Prion (2009) 0.92
Prion transmission prevented by modifying the β2-α2 loop structure of host PrPC. J Neurosci (2014) 0.90
Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein. PLoS Pathog (2013) 0.89
Generation of prions in vitro and the protein-only hypothesis. Prion (2010) 0.88
Multimodal fluorescence microscopy of prion strain specific PrP deposits stained by thiophene-based amyloid ligands. Prion (2014) 0.88
Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171. PLoS Pathog (2011) 0.88
Comparative analysis of essential collective dynamics and NMR-derived flexibility profiles in evolutionarily diverse prion proteins. Prion (2011) 0.87
Fibril formation of the rabbit/human/bovine prion proteins. Biophys J (2011) 0.87
Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C). Prion (2010) 0.86
De novo prion aggregates trigger autophagy in skeletal muscle. J Virol (2013) 0.86
Introducing a rigid loop structure from deer into mouse prion protein increases its propensity for misfolding in vitro. PLoS One (2013) 0.85
Chimeric elk/mouse prion proteins in transgenic mice. J Gen Virol (2012) 0.85
Structural plasticity of the cellular prion protein and implications in health and disease. Proc Natl Acad Sci U S A (2013) 0.85
Naturally prion resistant mammals: a utopia? Prion (2012) 0.85
Ethics in prion disease. Prog Neurobiol (2013) 0.83
Constraining the loop, releasing prion infectivity. Proc Natl Acad Sci U S A (2008) 0.83
Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions. Int J Cell Biol (2013) 0.82
Structural definition is important for the propagation of the yeast [PSI+] prion. Mol Cell (2013) 0.82
Striatal pathology underlies prion infection-mediated hyperactivity in mice. Prion (2010) 0.81
Fluorescent oligo and poly-thiophenes and their utilization for recording biological events of diverse origin-when organic chemistry meets biology. J Chem Biol (2009) 0.81
A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers. PLoS Pathog (2015) 0.81
From prion diseases to prion-like propagation mechanisms of neurodegenerative diseases. Int J Cell Biol (2013) 0.81
Association of tissue lineage and gene expression: conservatively and differentially expressed genes define common and special functions of tissues. BMC Bioinformatics (2010) 0.80
Could immunomodulation be used to prevent prion diseases? Expert Rev Anti Infect Ther (2012) 0.80
Disulfide mapping reveals the domain swapping as the crucial process of the structural conversion of prion protein. Prion (2011) 0.80
The effect of β2-α2 loop mutation on amyloidogenic properties of the prion protein. FEBS Lett (2013) 0.79
Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions. Sci Rep (2015) 0.79
De novo mammalian prion synthesis. Prion (2009) 0.79
Spontaneous generation of infectious prion disease in transgenic mice. Emerg Infect Dis (2013) 0.79
Nanoscopic and photonic ultrastructural characterization of two distinct insulin amyloid states. Int J Mol Sci (2012) 0.79
Amyloid fibrils from the N-terminal prion protein fragment are infectious. Proc Natl Acad Sci U S A (2016) 0.78
N-terminal helix-cap in α-helix 2 modulates β-state misfolding in rabbit and hamster prion proteins. PLoS One (2013) 0.78
De novo prions. F1000 Biol Rep (2010) 0.78
Disruption of the X-loop turn of the prion protein linked to scrapie resistance. Protein Eng Des Sel (2012) 0.78
Cytosolic PrP can participate in prion-mediated toxicity. J Virol (2014) 0.77
Towards authentic transgenic mouse models of heritable PrP prion diseases. Acta Neuropathol (2016) 0.77
Prion replication without host adaptation during interspecies transmissions. Proc Natl Acad Sci U S A (2017) 0.76
Tracking protein aggregate interactions. Prion (2011) 0.76
Specificity, Size, and Frequency of Spaces That Characterize the Mechanism of Bulk Transepithelial Transport of Prions in the Nasal Cavities of Hamsters and Mice. J Virol (2016) 0.76
Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9. PLoS One (2016) 0.75
De Novo Generation of a Unique Cervid Prion Strain Using Protein Misfolding Cyclic Amplification. mSphere (2017) 0.75
Mapping the Broad Structural and Mechanical Properties of Amyloid Fibrils. Biophys J (2017) 0.75
Complex folding and misfolding effects of deer-specific amino acid substitutions in the β2-α2 loop of murine prion protein. Sci Rep (2015) 0.75
Structural transitions in full-length human prion protein detected by xenon as probe and spin labeling of the N-terminal domain. Sci Rep (2016) 0.75
Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein. PLoS One (2017) 0.75
Prion protein β2-α2 loop conformational landscape. Proc Natl Acad Sci U S A (2017) 0.75
Genetic human prion disease modelled in PrP transgenic Drosophila. Biochem J (2017) 0.75
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature (2007) 10.02
Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J (1996) 6.66
NMR structure of the mouse prion protein domain PrP(121-231). Nature (1996) 6.37
NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A (2000) 4.80
Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature (1989) 4.69
Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science (1990) 4.19
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell (1998) 3.59
Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med (1992) 3.41
An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc Natl Acad Sci U S A (2001) 3.26
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell (1994) 2.68
Prion strain discrimination using luminescent conjugated polymers. Nat Methods (2007) 2.62
Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci (2001) 2.60
NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A (2000) 2.56
Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J (2003) 2.51
Prion protein gene variation among primates. J Mol Biol (1995) 2.43
Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron (1998) 2.40
Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev (1996) 2.39
Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci U S A (1994) 2.37
Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP. J Virol (2004) 2.34
Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J (2007) 2.27
Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J (2007) 2.12
Transmission of elk and deer prions to transgenic mice. J Virol (2006) 2.03
Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci U S A (2005) 2.01
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J (1999) 1.96
Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J (2005) 1.83
Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J Virol (2000) 1.66
Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci U S A (2005) 1.66
Colorimetric and fluorometric detection of nucleic acids using cationic polythiophene derivatives. Angew Chem Int Ed Engl (2002) 1.51
A versatile prion replication assay in organotypic brain slices. Nat Neurosci (2007) 1.41
Strain fidelity of chronic wasting disease upon murine adaptation. J Virol (2006) 1.40
Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A (2000) 1.31
Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis (2002) 1.28
Antiprion immunotherapy: to suppress or to stimulate? Nat Rev Immunol (2004) 1.09
Conjugated polyelectrolytes--conformation-sensitive optical probes for staining and characterization of amyloid deposits. Chembiochem (2006) 1.07
Prions and the immune system: a journey through gut, spleen, and nerves. Adv Immunol (2003) 1.05
Ser170 controls the conformational multiplicity of the loop 166-175 in prion proteins: implication for conversion and species barrier. FASEB J (2007) 1.01
First experimental transmission of fatal familial insomnia. Nature (1995) 0.98
Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits. J Neuropathol Exp Neurol (2006) 0.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol (2002) 11.20
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature (2012) 10.99
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci (2007) 6.23
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature (2011) 6.14
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science (2014) 5.47
Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS. J Biomol NMR (2002) 4.55
Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med (2005) 4.42
IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol (2011) 4.18
An EB1-binding motif acts as a microtubule tip localization signal. Cell (2009) 4.08
Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science (2010) 3.98
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med (2011) 3.96
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol (2002) 3.80
Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science (2009) 3.78
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 3.53
The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron (2004) 3.33
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell (2010) 3.25
The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol (2005) 3.14
Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci (2013) 3.11
Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol (2013) 3.08
Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci U S A (2006) 3.07
Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science (2012) 3.07
Metabolic flux responses to pyruvate kinase knockout in Escherichia coli. J Bacteriol (2002) 3.06
Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol (2005) 2.91
Automated projection spectroscopy (APSY). Proc Natl Acad Sci U S A (2005) 2.91
Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci (2009) 2.85
Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med (2003) 2.79
Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood (2008) 2.65
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 2.64
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest (2006) 2.63
Prion strain discrimination using luminescent conjugated polymers. Nat Methods (2007) 2.62
Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice. Nat Genet (2013) 2.62
Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell (2012) 2.50
Effective rotational correlation times of proteins from NMR relaxation interference. J Magn Reson (2005) 2.37
Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol (2007) 2.34
Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci U S A (2007) 2.30
Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J (2007) 2.27
Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci U S A (2009) 2.27
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med (2010) 2.25
The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog (2010) 2.17
NMR structure of the apoptosis- and inflammation-related NALP1 pyrin domain. Structure (2003) 2.15
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med (2004) 2.13
NMR analysis of a 900K GroEL GroES complex. Nature (2002) 2.12
Chronic lymphocytic inflammation specifies the organ tropism of prions. Science (2005) 2.07
Anomalous coronary artery arising from the opposite sinus: descriptive features and pathophysiologic mechanisms, as documented by intravascular ultrasonography. J Invasive Cardiol (2003) 2.06
An essential function for NBS1 in the prevention of ataxia and cerebellar defects. Nat Med (2005) 2.06
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat Neurosci (2013) 2.03
Nonredundant function of soluble LTα3 produced by innate lymphoid cells in intestinal homeostasis. Science (2013) 2.03
The latent promiscuity of newly identified microbial lactonases is linked to a recently diverged phosphotriesterase. Biochemistry (2006) 2.02
Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci U S A (2005) 2.01
Coincident scrapie infection and nephritis lead to urinary prion excretion. Science (2005) 1.94
Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent step in DeltainvG S. Typhimurium colitis. J Exp Med (2008) 1.92
Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity (2013) 1.89
Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J Clin Oncol (2007) 1.88
The JCSG high-throughput structural biology pipeline. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 1.87
T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice. Gastroenterology (2013) 1.77
Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology (2010) 1.75
IL-6 is required for glioma development in a mouse model. Oncogene (2004) 1.74
Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol (2004) 1.74
The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe (2009) 1.74
Aerosols transmit prions to immunocompetent and immunodeficient mice. PLoS Pathog (2011) 1.71
Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci U S A (2002) 1.70
Cell biology: Beyond the prion principle. Nature (2009) 1.70
The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One (2008) 1.70
PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat Med (2005) 1.66
Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci U S A (2005) 1.66
Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J Exp Med (2008) 1.65
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells. Hepatology (2013) 1.62
Membrane protein-lipid interactions in mixed micelles studied by NMR spectroscopy with the use of paramagnetic reagents. Chembiochem (2004) 1.62
Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol (2006) 1.60
Automated sequence-specific protein NMR assignment using the memetic algorithm MATCH. J Biomol NMR (2008) 1.59